Glow Medicinal: an archive of the published GLOW peptide literature.

What Glow Medicinal Is

Glow Medicinal archives the peer-reviewed research literature on the GLOW peptide blend — GHK-Cu, BPC-157, and TB-500 — and makes it legible: indexing the mechanistic findings, noting where evidence is strong, and being explicit about where it is absent.

The blend combines three constituents studied in independent preclinical and clinical literatures spanning more than three decades. This is an archive of that record, not a service of any kind. It employs no clinicians, gives no medical advice, and makes, sells, or dispenses nothing.

The word 'medicinal' in the name is editorial framing — a position relative to a body of medical-research literature, not a description of any service. There is no clinical consultation, diagnosis, or recommendation here.

Editorial Standards

Every quantitative claim on this site is cited to its published source. Our references are drawn from PubMed-indexed journals, PubMed Central, and ClinicalTrials.gov. We do not publish findings without citations and we do not invent citations.

Where constituent-level evidence exists, we report it with species, route, and dose context. Where blend-level evidence is absent — as it is for the GLOW combination — we say so explicitly. The blend caveat appears on the index, research, and benefits pages: no published controlled trial has examined GHK-Cu + BPC-157 + TB-500 as a single formulation. This is not a rhetorical disclaimer; it is the honest characterization of the literature as of the date of publication.

Regulatory status is reported factually: BPC-157 is an FDA Category 2 bulk drug substance (September 2023) and is prohibited by WADA under S0 (2022). TB-500 is prohibited by WADA under S2.3 (effective 2012). GHK-Cu is not currently listed on the WADA Prohibited List.

What This Site Does Not Do

Glow Medicinal does not:

• Recommend doses, protocols, or administration schedules for any compound.
• Provide consultation, prescriptions, or clinical guidance.
• Sell, link to, or point readers toward any peptide supplier.
• Speak for, or draw on, any clinician, pharmacist, or healthcare professional.
• Claim any physical address, phone number, or clinic location.
• Imply that this site offers treatment, consultation, or prescription services.

The GLOW peptide dosage page documents doses used in published research — study parameters, not recommendations. The frequently asked questions page answers directly from the published literature, not from clinical judgment.